MEDTRONIC HEART VALVES DIVISION EVOLUT FX DCS; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
|
Back to Search Results |
|
Model Number D-EVOLUTFX-2329 |
Device Problem
Device Dislodged or Dislocated (2923)
|
Event Date 03/12/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
Continuation of d10: product id l-evolutfx-2329 (lot: 0012050353); product type: 0195-heart valves; implant date ; explant date section d references the main component of the system.Other medical products in use during the event include: brand name evolut fx valve; product id evolutfx-26 (serial: (b)(6)); product type: 0195-heart valves; implant date (b)(6) 2024; explant date (b)(6) 2024.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Medtronic received information that during the implant of this transcatheter bioprosthetic valve, the patient had a type 0 bicuspid native valve.Pre-implant balloon aortic valvuloplasty (bav) as performed using an 18mm true balloon over a non-medtronic (lunderquist) guidewire.The valve (b)(6) crossed the annulus and was deployed.Echocardiogram was performed to confirm placement, and the delivery catheter system (dcs) nosecone was attempted to be removed.As the nosecone came through the valve, the valve dislodged.The interventional cardiologist attempted to snare the dislodged valve (b)(6), as a second valve (b)(6) was loaded to attempt implant.However, the patient became unstable prior to attempting second valve implant and cardiopulmonary resuscitation (cpr) was initiated.The second valve (b)(6) was opened but not used, and discarded. the cardiovascular surgeon proceeded to take the patient to the operating room in order to explant the dislodged valve (b)(6) and perform a surgical aortic valve replacement (savr).The surgical valve was successfully implanted.No additional adverse patient effects were reported.
|
|
Manufacturer Narrative
|
Updated h.6 medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|
|
|